Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
A
Alseres Pharmaceuticals Inc. Stock Analysis ALSE
United States Health Care Nano Cap Alseres Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of diagnostic and therapeutic products for disorders in the central nervous system. The company is headquartered in Auburndale, Massachusetts. The firm is engaged in the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS). The firm's product candidate is Altropane. The firm's Altropane product is a molecular imaging agent used to diagnose Parkinson's disease and dementia. The firm is focused on entering partnerships to ensure development and commercialization of its product.
Read More Alseres Pharmaceuticals Inc (ALSE) Chart
Key Statistics of Alseres Pharmaceuticals Inc (ALSE)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.01Volume
66.00P/E Ratio (TTM)
-52 Week Range
Market Cap
150.00KAvg. Volume
66.00Dividend Yield
-Financial Metrics & Statements of Alseres Pharmaceuticals Inc (ALSE)
FAQ's for Alseres Pharmaceuticals Inc (ALSE)
- According to Musaffa’s Shariah screening methodology, Alseres Pharmaceuticals Inc (ALSE) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Alseres Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Alseres Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Alseres Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Alseres Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Alseres Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.